542
LETTER TO THE EDITOR
SYMPTOMATIC HYPOCALCEMIA
OWING TO ORAL RISEDRONATE
THERAPY
Sir,
A 21-year-old man was admitted to our
hospital because of intermittent diarrhea from
his childhood and weight loss. Physical
examination was normal (1.55 m height and
43 kg weight). Laboratory studies were as
follows; serum total calcium (Ca2+): 8.8 mg/
dl, phosphorus: 5 mg/dl, magnesium: 1.6 mg/
dl, albumin: 3.7 mg/dl, total protein: 5.7 mg/
dl. Serum sodium, potassium, alkaline
phosphatase levels, and renal, hepatic, and
thyroid function tests were normal. Serum
parathyroid hormone (PTH) level was 139 pg/
ml. Antigliadin immunoglobulin A (IgA)
antibody was positive. Severe villous atrophy
in the proximal intestine was found in
histopathologic examination. Bone mineral
densitometry (DEXA) revealed significant
osteoporosis (L1– L 4, Z, and T scores were 3.24 and -3.23, respectively). According to
these data, he was diagnosed with celiac
disease and implemented on a gluten free
diet, oral risedronate (35 mg/once a week),
oral calcium (elemental calcium 1800 mg/day)
and oral magnesium (1830 mg/day). Three
days after the starting dose of risedronate,
he experienced a full picture of hypocalcemia
with physical and laboratory findings
(albumin-corrected serum Ca2+ of 5.9 mg/dl)
including long QT interval in the ECG. Other
results were; phosphorus 3.1 mg/dl,
magnesium 1.7 mg/dl, and albumin 3.4 mg/
dl. Then, he was treated with intravenous
calcium gluconate. He recovered well with
this therapy, and discontinued risedronate and
continued with oral calcium, magnesium and
vitamin-D3 besides gluten free diet.
Use of the Naranjo adverse drug reaction
probability scale indicated a possible (score:
4) relationship between symptomatic
hypocalcemia and risedronate therapy in this
patient.[1]
543
LETTER TO THE EDITOR
caused hypomagnesemia as well. Since PTH
secretion is stimulated by magnesium
dependent adenly cyclase, it is possible that
hypomagnesemia exacerbated hypocalcemia
by interrupting the normal feedback loop.
Therefore, correction of the hypomagnesemia
seems essential in such patients.
In conclusion, symptomatic hypocalcemia is
a rare but possible complication of oral
risedronate therapy. Patients with celiac
disease should be checked for their calcium
and vitamin-D status, and carefully followedup during risedronate treatment.
REFERENCES
Bisphosphonates
are
recommended
especially in old patients with celiac disease,
and, given the serious consequences of
spontaneous fractures can also be considered
at younger ages.[2] These drugs, when given
intravenous, have occasionally been reported
to cause symptomatic hypocalcemia. [3]
However, as in the present case, it is quite
uncommon with oral administration[4,5] because
of compensatory mechanisms such as
increase in PTH secretion, which prevents
hypocalcemia by enhancing renal absorption
of calcium, vitamin-D production, and
stimulating osteoclastic bone resorption.
Depending on the potency of the
bisphosphonate, the effect of PTH on bone
resorption by osteoclasts is blocked to some
extent during bisphosphonate treatment.
Gastrointestinal calcium absorption occurs
mainly in the proximal ileum and decreases
towards the distal par ts. In our case, the
diarrhea might have impaired calcium
absorption in response to hypocalcemia.
Presumably, gastrointestinal calcium loss
Indian J Med Sci, Vol. 59, No. 10, October 2005
1. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I,
Roberts EA, et al., A method for estimating the
probability of adverse drug reactions. Clin
Pharmacol Ther 1981;30:239–45.
2. Scott EM, Gaywood I, Scott BB. Guidelines for
osteoporosis in coeliac disease and inflammatory
bowel disease. British Society of Gastroenterology.
Gut 2000;46(Suppl 1):i1–8.
3. Singh D, Khaira NS, Sekhon JS. Symptomatic
hypocalcaemia after treatment with zoledronic acid
in a patient with multiple myeloma. Ann Oncol 2004;
15:1848.
4. Johnson MJ, Fallon MT. Symptomatic
hypocalcemia with oral clodronate. J Pain Symptom
Manage 1998;15:140–2.
5. Mayordoma JI, Rivera F. Severe hypocalcaemia
after treatment with oral clodronate and
aminoglycoside. Ann Oncol 1993;4:432–3.
SARCOMATOID CARCINOMA IN
A BLADDER DIVERTICULUM —
A RARE CASE
Sir,
Sarcomatoid carcinoma are those, which
exhibit a prominent spindle cell component.
They are aggressive tumours with a poor
prognosis and should be differentiated from
true carcinosarcoma.[1] So far, only two cases
of sarcomatoid carcinoma in a bladder
diverticulum have been reported.
This 56-year-old patient presented with total
painless hematuria of 1-month duration.
Physical examination was negative. CT
examination showed a large bladder
diverticulum containing an irregular contrast
enhancing mass (Figure 1). On cystoscopy,
a large diverticulum with a nodulopapillary
tumour with keratin material on surface was
seen. Biopsy of the tumour reported a high
grade spindle cell neoplasm. The patient
underwent bilateral pelvic lmphadenectomy,
radical cystoprostatectomy with MAINZ II
T. DOGRU, A. SONMEZ, I. TASCI, H. GENC
Gulhane Medical School, Department of Internal Medicine,
Etlik, Ankara, Turkey
Correspondence
Teoman Dogru.
Gulhane Medical School, Department of Internal Medicine,
Etlik, 06018, Turkey E-mail: teomandogru@yahoo.com
Indian J Med Sci, Vol. 59, No. 10, October 2005
Figure 1: Contrast enhanced CT scan showing the
neck of the diverticulum communicating with bladder
LETTER TO THE EDITOR
ureterosigmoidostomy. The lymph nodes and
resected
margins
were
negative.
Histopathology repor t proved to be
sarcomatoid carcinoma. The tumor was
composed of transitional cell carcinoma
(TCC), sarcomatous spindle cells and the
area of transition between TCC and spindle
cells [Figure 2(inset)]. Immunohistochemical
examination showed that the spindle cells and
the area of transition were strongly positive
for vimentin and weakly positive for
cytokeratin (Figure 2). The histopathological
and immunohistochemical transition between
the TCC and the spindle cells implies that the
sarcomatous elements originated from the
TCC during tumour progression. The patient
expired 6 months after surgery with extensive
pelvic lymph node recurrence and lung
metastasis.
The occurrence of a tumor inside a
diverticulum is relatively rare. The TCC is the
commonest tumor seen in a diverticulum.
About 19 cases of intradiverticular sarcomas
and carcinosarcomas have been reported in
Figure 2: Microphotograph (100x) showing strongly
positive vimentin areas. (Inset) Microphotograph (400
x) shows pleiomorphic sarcomatoid cells with hyper
chromatic nuclei (H&E staining)
544
the literature. Of these only two cases are of
sarcomatoid carcinoma. [2] Patients with
intradiverticular tumours usually present with
hematuria, voiding difficulty, palpable mass.
Neoplasms originating in a bladder
diver ticulum are character ized by ear ly
transmural invasion and tendency for higher
histopathological grades.[3] This makes early
diagnosis and treatment imperative in these
tumours. Filling defects caused by
intradiverticular tumors may not always be
visualized in intravenous urogram (IVU) and
cystography. Cross-sectional imaging studies
like US, CT, and magnetic resonance imaging
(MRI) are being used with greater accuracy
in the diagnosis and staging of
intradiver ticular tumours. MRI imaging in
oblique planes can facilitate the diagnosis by
demonstrating the neck of the diverticulum.
Also, T2 weighted images allow differentiation
between tumor in a diver ticulum and a
necrotic extravesical mass. [4] Cystoscopic
findings of keratin materials and fast growing
tumours also warrant special attention. As in
our case, these signify a more sinister
pathology than the usual TCC. Cystoscopic
biopsy may not be diagnostic always as
superficial biopsy may be inconclusive. The
neoplasm’s or iginating in a bladder
diver ticulum are character ized by ear ly
transmural invasion and high incidence of
local recurrence. [5] The previously reported
cases treated with partial cystectomy had
rapid intra abdominal recurrences and dismal
prognosis. Our case demonstrates the
accuracy of CT in detecting intradiverticular
tumours. Obtaining a deep biopsy by
cystoscopy is essential for diagnosis. The
intradiver ticular sarcoma and sarcomatoid
carcinoma portend a poor prognosis even
Indian J Med Sci, Vol. 59, No. 10, October 2005
545
LETTER TO THE EDITOR
with aggressive surgical resection.
REFERENCES
1. Young RH, Wick MR, Mills SE. Sarcomatoid
carcinoma of the urinar y bladder. A
clinicopathologic analysis of 12 cases and review
of the literature. Am J Clin Pathol. 1988; 90: 653–61
2. Kim MY, Jeon YS, Suh CH, Park WH. Sarcomatoid
carcinoma arising from the diverticulum of the
urinary bladder dome: a difficult diagnosis with
imaging. Am. J. Roentgenol. 1999; 172: 1454-5
3. Yagci C, Atasoy C, Fitoz S, Akyar S. Cross sectional
imaging findings in intradiverticular bladder tumor
a case report. Tani Girisim Radyol.2003; 9:452-5
4. Durfee SM, Schwartz LH, Panicek DM, Russo P.
MR imaging of carcinoma within bladder
diverticulum. Clinical Imaging 1997; 21:290-2
5. Cheng CW, Ng MT, Cheung HY, Sun WH, Chan
LW, Wong WS, Lai FM. Carcinosarcoma of the
bladder diverticulum and a review of the literature.
Int J Urol. 2004; 11:1136-8.
T. A. KISHORE, S. BHAT, A. S. ALBERT,
J. AUGUSTINE
Department of Urology and Pathology, Medical College,
Kottayam, Kerala, India
Correspondence
TA Kishore
Department of Urology, Medical College, Kottayam – 686008,
Kertala, India, E-mail: kishoreta@yahoo.com
Indian Journal of Medical Sciences is pleased to announce the launch of its
website. The URL of the website is http://www.indianjmedsci.org.
The features of the site are:
•
•
•
•
•
•
•
•
•
Free full text availability of articles in HTML as well as PDF
Link to abstracts and full text from the cited references
Link to PubMed abstracts of published articles by authors
Link to related articles in PubMed
Link from text of articles to various databases and search engines
Facility to submit comments on articles
Email notifications on new issue release
Statistics of articles download and visits
Structure based on OpenURL, DC Metadata and other international standards
Indian J Med Sci, Vol. 59, No. 10, October 2005